Corporate Members
Boehringer Ingelheim Taiwan Limited

G.M.:James Chiou
Capital :

Boehringer Ingelheim

Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.


Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.


Boehringer Ingelheim, Taiwan has served in Taiwan since 1975 as a healthy issue solution provider with nearly 300 employees and 5 different offices located in north, central and south Taiwan. With core business in Human Pharm and Animal Health, we support patients in the area of the respiratory, oncology, diabetes, cardiovascular, Parkinson's disease, fibrosis disease, HIV and more. We support companion animals and their owners in parasite prevention and the treatment for heart disease, also support Livestock farmer in serval disease prevention, such as porcine reproductive and respiratory syndrome, Newcastle Disease and more.


Boehringer Ingelheim, Taiwan has become the fastest growing and most innovative company within the industry in recent years. Also, Boehringer Ingelheim is the only company received Top Employer Recognition for 3 years in a row in 2016, 2017 and 2018.


As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.


More information about Boehringer Ingelheim can be found on (Corporate Website) (Taiwan Website) (Social Responsibility Facebook Page) (Animal Health Facebook Page) (2017 Annual Report)